Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_provenance.
- NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_assertion description "[The two essential requirements for pathologic specimens in the era of personalized therapies for non-small cell lung carcinoma (NSCLC) are accurate subtyping as adenocarcinoma (ADC) versus squamous cell carcinoma (SqCC) and suitability for EGFR and KRAS molecular testing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_provenance.
- NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_assertion evidence source_evidence_literature NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_provenance.
- NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_assertion SIO_000772 21266922 NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_provenance.
- NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_assertion wasDerivedFrom befree-2016 NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_provenance.
- NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_assertion wasGeneratedBy ECO_0000203 NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_provenance.
- befree-2016 importedOn "2016-02-19" NP867733.RAtG04VjiDyzIsxPWdBv0bk2E2I37YJD9uJZIDT8FAIdg130_provenance.